Hélène Blons

10.9k citations

165 papers · 6.0k indexed · 1 hit paper · h-index 47

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Cancer Research 62
- Cancer Genomics and Diagnostics 54
Oncology 94
- Colorectal Cancer Treatments and Studies 32
- Lung Cancer Research Studies 16
- Cancer Immunotherapy and Biomarkers 10

Co-authors: Pierre Laurent‐Puig (111 shared papers)Audrey Didelot (22 shared papers)Philippe Beaune (11 shared papers)Valérie Taly (22 shared papers)Astrid Lièvre (4 shared papers)Karine Pallier (11 shared papers)Marie Wislez (21 shared papers)Daniel Brasnu (13 shared papers)
Journals: Annals of Oncology (15 papers)Journal of Clinical Oncology (12 papers)Lung Cancer (8 papers)Clinical Cancer Research (7 papers)International Journal of Cancer (6 papers)
Partner nations: France Italy Germany

In The Last Decade

Hélène Blons

157 papers receiving 6.0k citations

Hit Papers

align trajectories log scale

Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives 2013 · 489 citations

Peers

Countries citing papers authored by Hélène Blons

Since Specialization

Citations

This map shows the geographic impact of Hélène Blons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Blons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Blons more than expected).

Fields of papers citing papers by Hélène Blons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Blons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Blons. The network helps show where Hélène Blons may publish in the future.

Co-authors

The 25 scholars most cited alongside Hélène Blons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hélène Blons Line = papers co-authored together Hélène Blons links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives Journal of Clinical Oncology ·Julien Mazières, Solange Peters, Benoît Lepage, Alexis B. Cortot, Fabrice Barlési, Michèle Beau‐Faller, Benjamin Besse, Hélène Blons, Audrey Mansuet-Lupo, T. Urban, Denis Moro‐Sibilot, Éric Dansin, C. Chouaïd, Marie Wislez, Joachim Diebold, Enriqueta Felip, Isabelle Rouquette, Julie Milia, Oliver Gautschi Hit paper breakdown →	2013	489
2	Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients Clinical Chemistry ·Valérie Taly, Deniz Pekin, Léonor Benhaïm, Steve K. Kotsopoulos, Delphine Le Corre, Xinyu Li, Ivan Atochin, Darren R. Link, Andrew D. Griffiths, Karine Pallier, Hélène Blons, Olivier Bouché, Bruno Landi, J. Brian Hutchison, Pierre Laurent‐Puig	2013	380
3	Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction Journal of the American College of Cardiology ·Philippe Menasché, Valérie Vanneaux, Albert Hagège, Alain Bel, Bernard Cholley, Alexandre Parouchev, Isabelle Cacciapuoti, Reem Al‐Daccak, Nadine Benhamouda, Hélène Blons, Onnik Agbulut, Lucie Tosca, Jean‐Hugues Trouvin, Jean‐Roch Fabreguettes, Valérie Bellamy, Dominique Charron, Éric Tartour, Gérard Tachdjian, Michel Desnos, Jérôme Larghero	2018	305
4	TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma Clinical Cancer Research ·Jérôme Biton, Audrey Mansuet‐Lupo, Nicolas Pécuchet, Marco Alifano, Hanane Ouakrim, Jennifer Arrondeau, Pascaline Boudou‐Rouquette, François Goldwasser, Karen Leroy, Jérémy Goc, Marie Wislez, Claire Germain, Pierre Laurent‐Puig, Marie‐Caroline Dieu‐Nosjean, Isabelle Cremer, Ronald Herbst, Hélène Blons, Diane Damotte	2018	251
5	Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosis International Journal of Cancer ·Thierry Lecomte, Anne Berger, Franck Zinzindohoué, Stéphanie Micard, Bruno Landi, Hélène Blons, Philippe Beaune, Paul‐Henri Cugnenc, Pierre Laurent‐Puig	2002	245
6	Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial The Lancet Oncology ·Julien Taı̈eb, Josep Tabernero, Enrico Mini, Fabien Subtil, Gunnar Folprecht, Jean-Luc Van Laethem, J. Thaler, John Bridgewater, Lone Nørgård Pétersen, Hélène Blons, Laurence Collette, Eric Van Cutsem, Philippe Rougier, Ramón Salazar, Laurent Bedenne, Jean‐François Emile, Pierre Laurent‐Puig, Côme Lepage	2014	188
7	Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study) Clinical Cancer Research ·Fanny Garlan, Pierre Laurent‐Puig, David Sefrioui, Nathalie Siauve, Audrey Didelot, Nasrin Sarafan‐Vasseur, Pierre Michel, Géraldine Perkins, Claire Mulot, Hélène Blons, Julien Taı̈eb, Frédéric Di Fiore, Valérie Taly, Aziz Zaanan	2017	165
8	p53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Series Journal of Clinical Oncology ·Arnauld Cabelguenne, Hélène Blons, Isabelle de Waziers, Françoise Carnot, Anne‐Marie Houllier, Thierry Soussi, Daniel Brasnu, Philippe Beaune, O. Laccourreye, Pierre Laurent‐Puig	2000	151
9	Detection of BRAF p.V600E Mutations in Melanomas Journal of Molecular Diagnostics ·Émeline Colomba, Zofia Hélias‐Rodzewicz, Andreas von Deimling, Cristi Marin, Nathalie Terrones, Dominique Pechaud, Sylvie Surel, Jean‐François Côté, Frédérique Peschaud, David Capper, Hélène Blons, U. Zimmermann, T. Clérici, Philippe Saïag, Jean‐François Emile	2012	125
10	Prognostic Effect ofBRAFandKRASMutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab JAMA Oncology ·Julien Taı̈eb, Aziz Zaanan, Karine Le Malicot, Catherine Julié, Hélène Blons, Laurent Mineur, Jaafar Bennouna, Josep Tabernero, Enrico Mini, Gunnar Folprecht, Jean‐Luc Van Laethem, Côme Lepage, Jean‐François Emile, Pierre Laurent‐Puig	2016	121
11	Mutations and Response to Epidermal Growth Factor Receptor Inhibitors Clinical Cancer Research ·Pierre Laurent‐Puig, Astrid Lièvre, Hélène Blons	2009	101
12	Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples Experimental and Molecular Pathology ·Audrey Didelot, Delphine Le Corre, Armelle Luscan, Aurélie Cazes, Karine Pallier, Jean‐François Emile, Pierre Laurent‐Puig, Hélène Blons	2012	91
13	Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study Cancers ·Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux‐Leprieur, Elizabeth Fabre, Marie Wislez, Marco Alifano, Karen Leroy, Pascaline Boudou‐Rouquette, Camille Tlemsani, Nihel Khoudour, Jennifer Arrondeau, Audrey Thomas‐Schoemann, Hélène Blons, Audrey Mansuet‐Lupo, Diane Damotte, Michel Vidal, François Goldwasser, Jérôme Alexandre, Benoı̂t Blanchet	2020	91
14	Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset Annals of Oncology ·Hélène Blons, Jean‐François Emile, Karine Le Malicot, C. Julié, Aziz Zaanan, Josep Tabernero, Enrico Mini, Gunnar Folprecht, Jean‐Luc Van Laethem, J. Thaler, John Bridgewater, L. Nørgård-Petersen, Eric Van Cutsem, Côme Lepage, Mohamed-Ayman Zawadi, Ramón Salazar, Pierre Laurent‐Puig, Julien Taı̈eb	2014	88
15	Oncogenic mutations as predictive factors in colorectal cancer Oncogene ·Astrid Lièvre, Hélène Blons, Pierre Laurent‐Puig	2010	88
16	Multiplex Picoliter-Droplet Digital PCR for Quantitative Assessment of DNA Integrity in Clinical Samples Clinical Chemistry ·Audrey Didelot, Steve K. Kotsopoulos, Audrey Lupo, Deniz Pekin, Xinyu Li, Ivan Atochin, Preethi Srinivasan, Qun Zhong, Jeff Olson, Darren R. Link, Pierre Laurent‐Puig, Hélène Blons, J. Brian Hutchison, Valérie Taly	2013	86
17	Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations PLoS ONE ·Eleonora Zonta, Fanny Garlan, Nicolas Pécuchet, Karla Perez‐Toralla, Ouriel Caën, Coren A. Milbury, Audrey Didelot, Elizabeth Fabre, Hélène Blons, Pierre Laurent‐Puig, Valérie Taly	2016	82
18	Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. PubMed ·Florence Coulet, Hélène Blons, Arnaud Cabelguenne, Thierry Lecomte, O Lacourreye, Daniel Brasnu, Philippe Beaune, Jessica Zucman‐Rossi, Pierre Laurent‐Puig	2000	81
19	Epidermal Growth Factor Receptor Mutation in Lung Cancer are Linked to Bronchioloalveolar Differentiation The American Journal of Surgical Pathology ·Hélène Blons, Jean‐François Côté, Delphine Le Corre, Marc Riquet, Elizabeth Fabre-Guillevin, Pierre Laurent‐Puig, Claire Danel	2006	76
20	The New Histologic Classification of Lung Primary Adenocarcinoma Subtypes Is a Reliable Prognostic Marker and Identifies Tumors With Different Mutation Status CHEST Journal ·Audrey Mansuet‐Lupo, Antonio Bobbio, Hélène Blons, Étienne Becht, Hanane Ouakrim, Audrey Didelot, Marie-Christine Charpentier, Serge Bain, B Marmey, Patricia Bonjour, Jérôme Biton, Isabelle Cremer, Marie‐Caroline Dieu‐Nosjean, Catherine Sautès‐Fridman, Jean‐François Régnard, Pierre Laurent‐Puig, Marco Alifano, Diane Damotte	2014	76

About Hélène Blons

Hélène Blons is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 165 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (54 papers), Lung Cancer Treatments and Mutations (54 papers), Genetic factors in colorectal cancer (38 papers), Colorectal Cancer Treatments and Studies (32 papers), Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Research Studies (16 papers), RNA modifications and cancer (13 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (3.3k citations), Pulmonary and Respiratory Medicine (2.4k citations), Pathology and Forensic Medicine (1.2k citations) and Otorhinolaryngology (148 citations). Hélène Blons has collaborated with scholars based in France, Italy and Germany. Frequent co-authors include Pierre Laurent‐Puig, Audrey Didelot, Philippe Beaune, Valérie Taly, Astrid Lièvre, Karine Pallier, Marie Wislez, Daniel Brasnu, Delphine Le Corre and Jean‐François Emile. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Lung Cancer, Clinical Cancer Research and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact